资讯 | 网易有道公布2019年年报,A股基建股持续走强

资讯摘要
美股周四再遭血腥屠戮,三大股指跌幅超过4.4%,均跌入回调区域。道指尾盘跳水收跌逾1190点,一度狂泻超过1200点。中国境外的新冠病毒疫情不断蔓延,美国确诊首例病源不明的患者。众多企业与分析师纷纷发布预警,投资者担心疫情将打击全球经济。原油期货价格重挫。
 
美股资讯
北京时间2月28日凌晨,美股周四再遭血腥屠戮,三大股指跌幅超过4.4%,均跌入回调区域。道指尾盘跳水收跌逾1190点,一度狂泻超过1200点。中国境外的新冠病毒疫情不断蔓延,美国确诊首例病源不明的患者。众多企业与分析师纷纷发布预警,投资者担心疫情将打击全球经济。原油期货价格重挫。

截止收盘,道指收盘下跌1190.95点,或4.42%,报25766.64点;纳指跌414.30点,或4.61%,报8566.48点;标普500指数跌137.63点,或4.42%,报2978.76点。

周四尾盘道指一度下跌超过1200点,最低下跌至25752.82点。道指成分股中,陶氏化学、微软、苹果、埃克森美孚、英特尔、波音、宝洁、美国运通、高盛、可口可乐等均大幅下挫。

受油价大跌影响,切萨皮克能源、Yuma Energy、斯伦贝谢、马拉松能源、埃克森美孚、雪佛龙、英国石油跌等石油股集体走低。

美国总统特朗普周三晚间举行的新闻发布会未能使投资者放心、中国境外报道的新增确诊病例连续第二天超过境内,令周四美股市场继续承压。

当地时间27日,世卫组织总干事谭德塞在日内瓦表示,截至日内瓦时间27日早晨6点,中国境外共有44个国家出现总计3474例新冠肺炎病例,54例死亡,巴西、格鲁吉亚、希腊、北马其顿、挪威、巴基斯坦和罗马尼亚共7个国家首次上报了新冠肺炎病例。谭德塞表示,目前正处于决定性时刻,25日、26日连续两天中国境外上报的新冠肺炎新增病例数均超过中国新增病例数,伊朗、意大利、韩国的新冠肺炎疫情较为严重。

焦点个股受全球公共卫生事件影响下,Tonix Pharmaceuticals、阿尔法科技、NanoViricides、Inovio Pharmaceuticals及Co-Diagnostics等美股病毒预防治疗板块继续走高。

吉利德科学启动两项瑞德西韦三期临床研究。从今年3月开始,这两项临床试验将入组约1000名患者,结果将于5月份公布。

特斯拉公司1月份在中国的新车注册量环比下降46%。

百威英博报告称,第四财季归属于百威英博股东的正常化利润为9.62亿美元,同比下滑32%,每股收益为0.48美元,去年同期为0.71美元。

网易有道27日发布2019年第四季度及全年未经审计财务报告。财报显示,网易有道2019年第四季度营收4.1亿,其中,学习型产品和服务营收达3.1亿,同比增长128.6%,占总营收比例近八成。由在线课程、智能硬件为主要构成的学习型产品和服务已经成为网易有道主要营收来源。

同时,通过对课程产品和内容的打磨和快速迭代,网易有道率先在一批优势学科上取得突破。网易有道CEO周枫在财报中表示,公司的初中语文、初高中物理、成人实用英语和少儿编程课程的增长尤为明显。财报数据显示,2019年第四季度,公司在线课程销售额达3.5亿,同比增长211.1%。其中,有道精品课销售额达2.8亿,同比增长201.4%。

财报显示,截至2019年12月31日,网易有道现金、现金等价物、定存、短期投资总计为16亿元,在线课程递延收入达4.1亿元。

热点中概股
  
来源:东方财富网、同花顺、新浪财经、腾讯证券、华尔街见闻、辉立证券
 
港股资讯
北京时间2月27日,周三美国三大股指收盘涨跌不一,道指收跌逾120点,跌破27000点关口,盘中一度涨逾400点;道指和标普500指数连续5个交易日录得下跌。周四早盘,恒指窄幅震荡,午后南下资金不断买入,港股强势翻红。

截止收盘,,恒指涨0.31%,报26778.62点;红筹指数涨0.48%,国企指数涨0.87%。生物制药、内资银行、地产股涨幅居前,东阳光药涨超10%。

沪港通资金流向方面,沪股通净流出20.94亿,港股通(沪)净流入35.40亿。

深港通资金流向方面,深股通净流出18.48亿,港股通(深)净流入8.27亿。

 

热点板块

医药股集体爆发,东阳光药涨11%,歌礼制药大涨7.65%,阿里健康涨9.53%,翰森制药涨逾4%。歌礼制药(1672.HK)公布,由南昌市第九医院陈宏义主任团队发起的口服戈诺卫®联合利托那韦治疗新型冠状病毒肺炎临床研究,于2020年2月16日获南昌市第九医院伦理委员会批准。已有3例接受治疗的患者达到国家卫生健康委员会发布的出院标准后出院,其他入组的患者正在治疗中。

联想集团周三大跌5%,周四跌1.37%,报价5.03港元。2月26日晚,针对“有机构在社交媒体称联想集团疑似欺诈”一事,联想集团(00992)回应表示,“我们注意到某分析机构在没有发布任何报告的情况下,在Twitter上散布有关联想财务报告的误导性言论。

全天涨幅最大的5支港股通
来源:东方财富网、同花顺、新浪财经、腾讯证券、华尔街见闻、辉立证券
 
中国A股资讯
北京时间2月27日,,三大指数高开,开盘后指数震荡拉升,盘中三大指数一度翻绿,随后回升翻红,临近上午收盘,指数涨幅扩大,创指涨近2%。午后,三大指数小幅拉升后震荡回落,盘面上,口罩板块再度走强,总体上,两市个股涨跌参半,大盘总体赚钱效应一般,沪深两市成交额连续第七日破万亿元。

截止收盘,沪指报2991.33点,涨0.11%,成交额为3959.56亿元(上一交易日成交额为4953.41亿元);深成指报11534.02点,涨0.32%,成交额为6546.32亿元(上一交易日成交额为8173.49亿元)。

从盘面上看,医疗废物处理、酒店及餐饮、特高压等板块居板块涨幅榜前列,胎压监测、氮化镓、中船系等板块居板块下跌榜前列。

热门板块特高压概念股走强,国电南自、长高集团、风范股份涨停,国电南瑞等大幅跟涨。

消息面上,国家电网公司内部近日印发2020年重点工作任务,详细规划了电网建设、输配电成本、增量配电等十大类31项具体工作内容,其中电网建设部分内容再超预期。

酒店及餐饮回暖,西安饮食、华天酒店涨停,全聚德涨6%,金陵饭店、锦江酒店等纷纷跟涨。

消息面上,此前,商务部表示,疫情不会改变住宿餐饮等生活服务业快速发展、持续升级的趋势,疫情结束后预计住宿餐饮会迅速恢复。商务部会同相关部门进一步研究出台更有针对性的政策措施以支持企业渡过难关,同时还在研究疫情结束后振兴餐饮业的举措。

基建股盘中再度拉升,截至发稿,交建股份、山东路桥、宏润建设等涨停,新疆交建涨超6%

全天涨幅最大的5支沪港通

来源:东方财富网、同花顺、新浪财经、腾讯证券、华尔街见闻、辉立证券

联系我们开设账户

需要帮助吗?请分享您的详细资料,我们会给您答复。

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com